SEE 2021 - Volume 37 A & B

  • Claim Credits by 1/31/2022
  • Online Activity
Credits Available: CME

Part A is now available.
Part B will be available July 2021.

Expiration dates to claim credit:
37A: 1/31/2022
37B: 7/31/2022

Don't have time to read numerous journals? Discover emerging knowledge from the latest literature with Summaries of Emerging...  Read More +

Item Details

The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society of Anesthesiologists designates this enduring material for a maximum of 60 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

After successfully completing this activity, the learner will be able to:

  • Explain emerging concepts in anesthesia practice, as presented in the current literature.
  • Discuss the impact of emerging research on clinical practice.
  • Utilize this information to enhance his or her practice.
This activity is intended for anesthesiologists, anesthesiology residents, and members of the anesthesia care team.

Summaries of Emerging Evidence Editorial Board (SEE Volume 37A)
Wade A. Weigel, MD, FASA, Editor-in-Chief 
Seattle, Washington

Christopher Burkle, MD, JD, Medical Editor 
Rochester, Minnesota

Destiny F. Chau, MD
Little Rock, Arkansas

Gloria Cheng, MD

Dallas, Texas

Bianca M. Conti, MD 
Baltimore, Maryland

M. Denise Daley, MD
Houston, Texas

Neil A. Hanson, MD

Charlottesville, Virginia

Natalie F. Holt, MD, MPH 

Aberdeen, South Dakota

Norma J. Klein, MD 

Sacramento, California

Amy Robertson, MD 
Nashville, Tennessee

Naileshni S. Singh, MD
Sacramento, California

Task Force Members (SEE Volume 37A)
J. Kyle Bohman, MD
Rochester, Minnesota

Alyssa B. Brzenski, MD
San Diego, California

Sung “Jason” Chi, MD
Mountain View, California

Jarva Chow, MD
Chicago, Illinois

Dawn Dillman, MD
Portland, Oregon

Richard P. Dutton, MD, MBA, FASA
Dallas, Texas

Regina Y. Fragneto, MD, FASA
Georgetown, Kentucky

Vijay K. Gaba, MD, FASA
Fargo, North Dakota

Meera Gangadharan, MB, BS
Corpus Christi, Texas

Mary Beth Gibbons, MD
Covington, Kentucky

Ronald J. Gordon, MD, PhD
San Diego, California

Karla M. Greco, MD, FASA
Exeter, New Hampshire

Mary Ann Gurkowski, MD, FASA
San Antonio, Texas

Michael E. Harned, MD
Lexington, Kentucky

Latha Hebbar, MD
Mount Pleasant, South Carolina

Amy N. Huggins, MD
Little Rock, Arkansas

Kristyn B. Ingram, MD
El Paso, Texas

Trina M. Kleiver, MD
Little Rock, Arkansas

Gregg A. Korbon, MD
Charlottesville, Virginia

Michael Kushelev, MD
Columbus, Ohio

Andrea W. Martineau, MD
Norfolk, Virginia

Jeffrey McLaren, MD
Seattle, Washington

Vanessa A. Olbrecht, MD
Newport, Kentucky

Nathan L. Pace, MD, MStat
Salt Lake City, Utah

Roma Polce, MD
Las Vegas, Nevada

Karl A. Poterack, MD
Phoenix, Arizona

Aaron N. Primm, MD, FASA
New York, New York

Bridget P. Pulos, MD
Rochester, Minnesota

Muhammad B. Rafique, MB, BS, FASA
Elkhorn, Nebraska

Annette Rebel, MD, FASA
Nicholasville, Kentucky

Babak Roboubi, MD
Bethesda, Maryland

Barbara Rogers, MD, FASA
Powell, Ohio

Alex T. Suginaka, DO
Stillwater, Minnesota

Laurence Torsher, MD
Rochester, Minnesota

Jon Y. Zhou, MD
Elk Grove, California

ASA Staff: Kari L. Lee, Senior Managing Editor; Ginger Clark, Managing Editor; Rachel Winokur, Editor; Mark Grant, MD, PhD, Senior Methodologist


The American Society of Anesthesiologists remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of the American Society of Anesthesiologists to eliminate all situations of potential conflict of interest, but rather to enable those who are working with the American Society of Anesthesiologists to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. The American Society of Anesthesiologists educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all American Society of Anesthesiologists accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Disclosures (SEE Volume 37A)
The following SEE faculty and staff have reported the following relevant financial relationships with
commercial interests:

Ginger Clark
Merck & Co, Inc—Equity Position (self)

Richard P. Dutton, MD, MBA, FASA
Merck & Co, Inc—Consulting Fees (self)

Mark Grant, MD, PhD
Illumina Inc—Equity Position (self)

Nathan L. Pace, MD, MStat
Elute, Inc—Consulting Fees (self)

Jon Y. Zhou, MD
Avanos Medical—Consulting Fees (self)

All other planners, faculty, and staff members have disclosed no relevant financial relationships with commercial interests.

Internet connection. 

Web browser: Google Chrome, Internet Explorer, Microsoft Edge, Mozilla Firefox, or Safari, updated within the last 3 years.
SEE 2021 - Volume 37 A & B
SEE 2021 Products
Select SEE 2021 Products